Orkes Raises $60M as Developers Increasingly Use Its Platform to Deploy AI Confidently in Production [Yahoo! Finance]
Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely [Seeking Alpha]
Quest Diagnostics (DGX) had its price target raised by UBS Group AG from $210.00 to $220.00. They now have a "neutral" rating on the stock.
Quest Diagnostics deal helps push Secaucus office tower past 75% occupancy [Yahoo! Finance]
Quest Diagnostics (DGX) had its price target raised by Robert W. Baird from $224.00 to $229.00. They now have a "neutral" rating on the stock.